1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2015. Start Trial.
Date Value
September 11, 2026 -68.17%
September 10, 2026 -67.70%
September 09, 2026 -68.20%
September 08, 2026 -67.09%
September 04, 2026 -67.73%
September 03, 2026 -68.48%
September 02, 2026 -68.48%
September 01, 2026 -69.91%
August 31, 2026 -70.74%
August 28, 2026 -71.93%
August 27, 2026 -68.78%
August 26, 2026 -70.66%
August 25, 2026 -68.37%
August 24, 2026 -71.77%
August 21, 2026 -71.58%
August 20, 2026 -70.53%
August 19, 2026 -70.88%
August 18, 2026 -72.61%
August 17, 2026 -73.54%
August 14, 2026 -73.47%
August 13, 2026 -73.65%
August 12, 2026 -73.10%
August 11, 2026 -74.13%
August 10, 2026 -75.32%
August 07, 2026 -69.77%
Date Value
August 06, 2026 -74.78%
August 05, 2026 -65.32%
August 04, 2026 -64.89%
August 03, 2026 -64.78%
July 31, 2026 -64.18%
July 30, 2026 -63.11%
July 29, 2026 -64.10%
July 28, 2026 -64.62%
July 27, 2026 -64.04%
July 24, 2026 -68.23%
July 23, 2026 -69.58%
July 22, 2026 -67.27%
July 21, 2026 -66.15%
July 20, 2026 -66.84%
July 17, 2026 -65.46%
July 16, 2026 -64.10%
July 15, 2026 -64.43%
July 14, 2026 -64.74%
July 13, 2026 -64.89%
July 10, 2026 -64.82%
July 09, 2026 -64.16%
July 08, 2026 -61.73%
July 07, 2026 -62.53%
July 06, 2026 -64.09%
July 02, 2026 -65.84%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Emergent BioSolutions, Inc. -24.30%
Exelixis, Inc. 43.64%
ADMA Biologics, Inc. -42.71%
Arcutis Biotherapeutics, Inc. 35.02%
Relay Therapeutics, Inc. 358.0%